Eudocia Quant (Quant) Lee MD

Oncology•Boston, MA

Neuro-Oncology

Physician

Join to View Full Profile

450 Brookline AvenueDana Farber Cancer InsituteBoston, MA 02115
Phone+1 617-632-2166
Fax+1 617-632-4773

Education & Training

Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2003 - 2004
Washington University in St. Louis School of MedicineClass of 2003

Certifications & Licensure

MA State Medical License 2007 - 2026
ME State Medical License 2022 - 2026
NH State Medical License 2022 - 2026
VT State Medical License 2022 - 2026
RI State Medical License 2020 - 2020
American Board of Psychiatry and Neurology Neurology

Clinical Trials

A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Start of enrollment: 2008 Sep 01
Completed
Phase 2
Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2014 Jul 02
Terminated
Phase 1
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy Start of enrollment: 2015 May 01
Completed
Not Applicable
Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma Start of enrollment: 2015 Jul 13
Completed
Phase 2
Pembrolizumab In Central Nervous System Metastases Start of enrollment: 2016 Oct 01
Active, not recruiting
Phase 2
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma Start of enrollment: 2017 Nov 07
Active, not recruiting
Phase 2
Niraparib in Tumors Metastatic to the CNS Start of enrollment: 2022 Apr 05
RECRUITING
PHASE2
Roles: Contact, Principal Investigator
A Study of Abemaciclib in Recurrent Glioblastoma Start of enrollment: 2017 Feb 09
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.
Eudocia Q Lee, Brian M Alexander, Carlos G Romo, Jeffrey G Supko, Nathalie Y R Agar
Clinical Cancer Research. 2025-03-17
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.
Veronica Rendo, Eudocia Q Lee, Connor Bossi, Nicholas Khuu, Michelle A Rudek
Science Translational Medicine. 2025-02-19
liomaesourceutreachithupport: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patients.
Rachel Garcia Fox, Ugonma N Chukwueke, Timothy Sannes, Damien Miran, Daniel Chiu
Neuro-Oncology Practice. 2025-02-01

Lectures

Barriers to accrual and enrollment in brain tumor trials.
2019 ASCO Annual Meeting - 6/1/2019

Other

Anticoagulant and antiplatelet therapy in patients with brain tumors
Lee EQ, Wen PY
http://www.uptodate.com/contents/anticoagulant-and-antiplatelet-therapy-in-patients-with-brain-tumor
UpToDate, Wolters Kluwer Health - 2013-02-22
Neurologic complications of cancer treatment with biologic agents
Lee EQ, Wen PY
http://www.uptodate.com/contents/neurologic-complications-of-cancer-treatment-with-biologic-agents
UpToDate, Wolters Kluwer Health - 2013-02-25
Neurologic complications of non-platinum cancer chemotherapy
Lee EQ, Wen PY
http://www.uptodate.com/contents/neurologic-complications-of-non-platinum-cancer-chemotherapy
UpToDate, Wolters Kluwer Health - 2013-03-19
Neurologic complications of platinum-based chemotherapy
Lee EQ, Wen PY
http://www.uptodate.com/contents/neurologic-complications-of-platinum-based-chemotherapy
UpToDate, Wolters Kluwer Health - 2012-12-21
Join now to see all

Press Mentions

EMBARGOED: Study Reveals Activity of Navtemadlin in Glioblastoma, Points to Possible Treatment ImprovementsFebruary 19th, 2025
Kazia Executes Agreement to Commence GBM Agile Pivotal StudyOctober 16th, 2020
Kazia Therapeutics Executes Agreement to Begin GBM Agile Pivotal StudyOctober 15th, 2020